By Matt Olberding, Lincoln Journal Star
A Lincoln-based veterinary biotech company has secured a significant seed investment from local sources.
Thyreos, a vaccine company that is developing a novel vaccine platform that protects against herpesviruses, on Monday announced a $750,000 investment from Invest Nebraska, a nonprofit statewide venture development organization, and unnamed angel investors.